Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression
1997

The Role of p53 and Microvessel Count in Lung Cancer Prognosis

Sample size: 73 publication Evidence: high

Author Information

Author(s): G Fontanini, S Vignati, M Lucchi, A Mussi, A Calcinai, L Boldrini, S Chin, V Silvestri, CA Angeletti, F Basolo, G Bevilacqua

Primary Institution: University of Pisa

Hypothesis

The study investigates the prognostic impact of microvessel count and p53 protein overexpression in non-small-cell lung carcinoma (NSCLC) and their relationship with vascular endothelial growth factor (VEGF) expression.

Conclusion

The study concludes that microvessel count and p53 protein accumulation significantly impact the prognosis of NSCLC.

Supporting Evidence

  • Microvessel count and p53 accumulation significantly affect metastatic involvement, recurrence, and death.
  • High microvessel count is associated with shorter overall and disease-free survival.
  • VEGF expression is significantly lower in p53-negative and lowly vascularized tumors.

Takeaway

This study found that the number of blood vessels in lung tumors and the presence of a specific protein can help predict how well a patient will do.

Methodology

The study analyzed tumor samples from 73 patients using immunohistochemical methods to assess p53 expression, microvessel count, and VEGF expression.

Participant Demographics

66 men and 7 women with a mean age of 63 years.

Statistical Information

P-Value

P = 0.0009; P = 0.01; P = 0.0001; P = 0.0003; P = 0.02

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication